Annual Congress Amsterdam 2011

---

---

Molecular biomarkers at the bedside of critically ill patients

Symposium
Chairs: T. Welte (Hannover, Germany), S. Orfanos (Haidari, Greece)
Aims: The aims of this symposium are to:
- review studies of biomarkers with regard to its diagnosis and prognosis;
- discuss the attributes and pathogenetic relevance of molecular biomarkers needed to be clinical tools to assess the presence and activity of lung injury;
- review data on the potential use of pharmacogenomics in predicting susceptibility and prognosis and in determining treatment options in sepsis.

Biomarkers of early diagnosis and therapeutic response in ventilator-associated pneumonia A. Torres (Barcelona, Spain)
Are biomarkers helpful in sepsis for risk assessment or clinical trials? A. Artigas (Sabadell, Spain)